Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions for Prelude Therapeutics Inc (PRLD)

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
PRLDPrelude Therapeutics IncHuang JanePresident, CMOApr 04, 2024Option Exercise$4.743,34715,86551,287Apr 08, 2024, 04:11 PM
PRLDPrelude Therapeutics IncHuang JanePresident, CMOJan 04, 2024Option Exercise$3.773,84414,49245,259Jan 08, 2024, 05:00 PM
PRLDPrelude Therapeutics IncHuang JanePresident, CMOJul 04, 2023Option Exercise$4.653,24215,07530,353Jul 06, 2023, 04:35 PM
PRLDPrelude Therapeutics IncVaddi KrishnaCEOMay 24, 2023Buy$5.011,0005,0111,066,375May 26, 2023, 04:20 PM
PRLDPrelude Therapeutics IncVaddi KrishnaCEOMay 25, 2023Buy$5.319004,7791,067,275May 26, 2023, 04:20 PM
PRLDPrelude Therapeutics IncLim Bryant DavidChief Legal Officer, Corp Sec.May 24, 2023Buy$5.392,40012,9362,400May 25, 2023, 04:07 PM
PRLDPrelude Therapeutics IncChardonnet LaurentChief Financial OfficerMay 23, 2023Buy$5.505,00027,50042,165May 25, 2023, 04:05 PM
PRLDPrelude Therapeutics IncVaddi KrishnaCEOMay 23, 2023Buy$5.6311,85666,7491,065,375May 25, 2023, 04:03 PM
PRLDPrelude Therapeutics IncOrbiMed Capital GP VI LLCDirectorMay 22, 2023Buy$5.75869,5654,999,99910,119,756May 24, 2023, 05:09 PM
PRLDPrelude Therapeutics IncBonita David PDirectorMay 22, 2023Buy$5.75869,5654,999,99910,119,756May 24, 2023, 05:07 PM
PRLDPrelude Therapeutics IncHuang JanePresident, CMOApr 06, 2023Sale$6.1213,28081,27424,220Apr 06, 2023, 06:19 PM
PRLDPrelude Therapeutics IncVaddi KrishnaCEODec 20, 2022Buy$5.1319,18898,446120,665Dec 21, 2022, 04:08 PM
PRLDPrelude Therapeutics IncChardonnet LaurentChief Financial OfficerDec 08, 2022Buy$4.7610,00047,60035,873Dec 12, 2022, 09:13 AM
PRLDPrelude Therapeutics IncChardonnet LaurentChief Financial OfficerJun 01, 2022Buy$4.2310,00042,30024,500Jun 01, 2022, 04:31 PM
PRLDPrelude Therapeutics IncCombs AndrewEVP, Head of ChemistryMar 31, 2022Option Exercise$1.8936,06268,157304,442Apr 04, 2022, 05:08 PM
PRLDPrelude Therapeutics IncChardonnet LaurentChief Financial OfficerMar 21, 2022Option Exercise$7.516,50048,81514,500Mar 22, 2022, 06:01 PM
PRLDPrelude Therapeutics IncMorosini DeborahEVP, Chief of Clinical AffairsDec 15, 2021Sale$12.3557,502710,15829,195Dec 17, 2021, 05:20 PM
PRLDPrelude Therapeutics IncCombs AndrewEVP, Head of ChemistryDec 13, 2021Buy$12.124,00048,480264,380Dec 15, 2021, 05:21 PM
PRLDPrelude Therapeutics IncCombs AndrewEVP, Head of ChemistryDec 14, 2021Buy$11.604,00046,400268,380Dec 15, 2021, 05:21 PM
PRLDPrelude Therapeutics IncChardonnet LaurentChief Financial OfficerDec 13, 2021Option Exercise$12.285,00061,4008,000Dec 14, 2021, 05:37 PM
PRLDPrelude Therapeutics IncVaddi KrishnaPresident, CEODec 13, 2021Option Exercise$12.138,00097,0351,053,519Dec 14, 2021, 05:36 PM
PRLDPrelude Therapeutics IncMorosini DeborahEVP, Chief of Clinical AffairsNov 16, 2021Sale$14.3657,502825,98229,195Nov 18, 2021, 06:42 PM
PRLDPrelude Therapeutics IncMauro David JChief Medical OfficerOct 05, 2021Option Exercise$16.4230,000492,70015,000Oct 06, 2021, 06:02 PM
PRLDPrelude Therapeutics IncMauro David JChief Medical OfficerSep 07, 2021Sale$19.2930,000578,63315,000Sep 09, 2021, 04:53 PM
PRLDPrelude Therapeutics IncPierce ChristopherEVP and Chief of Business OperSep 02, 2021Sale$27.2634,000926,94320,750Sep 07, 2021, 07:17 PM
PRLDPrelude Therapeutics IncScherle PeggyChief Scientific OfficerAug 27, 2021Sale$18.6712,028224,567178,934Aug 30, 2021, 05:16 PM
PRLDPrelude Therapeutics IncScherle PeggyChief Scientific OfficerAug 26, 2021Option Exercise$18.313,40062,250174,620Aug 30, 2021, 05:16 PM
PRLDPrelude Therapeutics IncPiper BrianChief Financial OfficerAug 25, 2021Sale$17.6216,666293,5778,333Aug 27, 2021, 08:02 PM
PRLDPrelude Therapeutics IncScherle PeggyChief Scientific OfficerAug 13, 2021Option Exercise$18.304,57283,687175,206Aug 17, 2021, 04:44 PM
PRLDPrelude Therapeutics IncMauro David JChief Medical OfficerAug 05, 2021Sale$16.4930,000494,74415,000Aug 09, 2021, 04:26 PM
PRLDPrelude Therapeutics IncScherle PeggyChief Scientific OfficerJul 27, 2021Sale$18.4540,000737,980192,920Jul 29, 2021, 07:27 PM
PRLDPrelude Therapeutics IncMauro David JChief Medical OfficerJul 06, 2021Sale$14.6830,000440,45715,000Jul 08, 2021, 05:41 PM
PRLDPrelude Therapeutics IncMauro David JChief Medical OfficerJun 07, 2021Sale$17.1730,000514,97215,000Jun 09, 2021, 06:24 PM
PRLDPrelude Therapeutics IncPiper BrianChief Financial OfficerMay 25, 2021Sale$18.0816,666301,2878,333May 27, 2021, 05:03 PM
PRLDPrelude Therapeutics IncScherle PeggyChief Scientific OfficerMay 07, 2021Sale$21.1220,000422,492182,920May 11, 2021, 06:46 PM
PRLDPrelude Therapeutics IncPierce ChristopherEVP and Chief of Business OperApr 29, 2021Option Exercise$21.096,590138,9927,045Apr 30, 2021, 06:24 PM
PRLDPrelude Therapeutics IncMorosini DeborahEVP, Chief of Clinical AffairsApr 29, 2021Option Exercise$21.096,446135,9453,667Apr 30, 2021, 06:22 PM
PRLDPrelude Therapeutics IncMauro David JChief Medical OfficerApr 19, 2021Option Exercise$16.3950,000819,59925,000Apr 21, 2021, 07:56 PM
PRLDPrelude Therapeutics IncPierce ChristopherEVP and Chief of Business OperApr 08, 2021Option Exercise$20.944008,3783,950Apr 15, 2021, 07:12 PM
PRLDPrelude Therapeutics IncMorosini DeborahEVP, Chief of Clinical AffairsApr 08, 2021Option Exercise$20.942004,189544Apr 15, 2021, 07:11 PM
PRLDPrelude Therapeutics IncMauro David JChief Medical OfficerApr 08, 2021Sale$20.1219,234387,0289,617Apr 15, 2021, 07:09 PM
PRLDPrelude Therapeutics IncScherle PeggyChief Scientific OfficerApr 07, 2021Sale$20.3730,740626,123188,290Apr 09, 2021, 05:55 PM
PRLDPrelude Therapeutics IncPierce ChristopherEVP and Chief of Business OperApr 07, 2021Option Exercise$20.991,65634,7534,578Apr 09, 2021, 05:53 PM
PRLDPrelude Therapeutics IncMorosini DeborahEVP, Chief of Clinical AffairsApr 07, 2021Option Exercise$20.972,00041,9331,444Apr 09, 2021, 05:52 PM
PRLDPrelude Therapeutics IncMauro David JChief Medical OfficerApr 07, 2021Sale$20.6130,766634,09715,383Apr 09, 2021, 05:50 PM
PRLDPrelude Therapeutics IncBAKER JULIANDirectorJan 27, 2021Option Exercise$12.8510,376133,3329,252,951Jan 29, 2021, 07:04 PM
PRLDPrelude Therapeutics IncBonita David PDirectorSep 25, 2020Buy$19.001,236,80023,499,200917,412Sep 30, 2020, 07:52 PM
PRLDPrelude Therapeutics IncBAKER FELIXDirectorSep 29, 2020Buy$19.001,578,94729,999,9939,247,763Sep 30, 2020, 06:37 PM
PRLDPrelude Therapeutics IncCombs AndrewEVP, Head of ChemistrySep 29, 2020Buy$19.001,00019,000260,380Sep 29, 2020, 08:11 PM
PRLDPrelude Therapeutics IncORBIMED CAPITAL LLCDirectorSep 25, 2020Buy$19.001,236,80023,499,200917,412Sep 29, 2020, 08:10 PM
PRLDPrelude Therapeutics IncDier MardiDirectorSep 29, 2020Buy$19.0010,000190,00010,000Sep 29, 2020, 08:09 PM
PRLDPrelude Therapeutics IncMorosini DeborahEVP, Chief of Clinical AffairsSep 29, 2020Buy$19.004448,436444Sep 29, 2020, 08:08 PM
PRLDPrelude Therapeutics IncPierce ChristopherEVP and Chief of Business OperSep 29, 2020Buy$19.003,75071,2503,750Sep 29, 2020, 08:07 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe